Taro Pharmaceutical Industries Ltd. Net Profit Margin 2010-2023 | TARO
Taro Pharmaceutical Industries Ltd. net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $0.61B | $0.05B | 7.53% |
| 2023-09-30 | $0.59B | $0.03B | 5.56% |
| 2023-06-30 | $0.58B | $0.02B | 3.65% |
| 2023-03-31 | $0.57B | $0.03B | 4.36% |
| 2022-12-31 | $0.57B | $0.05B | 7.91% |
| 2022-09-30 | $0.57B | $0.06B | 11.25% |
| 2022-06-30 | $0.57B | $0.09B | 15.76% |
| 2022-03-31 | $0.56B | $0.06B | 10.16% |
| 2021-12-31 | $0.57B | $-0.00B | 0.00% |
| 2021-09-30 | $0.57B | $0.01B | 1.23% |
| 2021-06-30 | $0.58B | $0.03B | 5.02% |
| 2021-03-31 | $0.55B | $-0.39B | -70.49% |
| 2020-12-31 | $0.58B | $-0.30B | -52.60% |
| 2020-09-30 | $0.58B | $-0.27B | -45.89% |
| 2020-06-30 | $0.60B | $-0.26B | -42.69% |
| 2020-03-31 | $0.65B | $0.24B | 37.83% |
| 2019-12-31 | $0.65B | $0.25B | 38.15% |
| 2019-09-30 | $0.68B | $0.27B | 40.41% |
| 2019-06-30 | $0.68B | $0.28B | 41.57% |
| 2019-03-31 | $0.67B | $0.28B | 42.09% |
| 2018-12-31 | $0.67B | $0.31B | 46.62% |
| 2018-09-30 | $0.64B | $0.23B | 36.34% |
| 2018-06-30 | $0.66B | $0.22B | 34.05% |
| 2018-03-31 | $0.66B | $0.21B | 31.77% |
| 2017-12-31 | $0.68B | $0.21B | 30.35% |
| 2017-09-30 | $0.75B | $0.33B | 44.04% |
| 2017-06-30 | $0.81B | $0.40B | 49.75% |
| 2017-03-31 | $0.88B | $0.46B | 51.99% |
| 2016-12-31 | $0.95B | $0.49B | 51.58% |
| 2016-09-30 | $0.99B | $0.54B | 54.56% |
| 2016-06-30 | $0.97B | $0.55B | 56.45% |
| 2016-03-31 | $0.95B | $0.54B | 56.95% |
| 2015-12-31 | $0.93B | $0.58B | 62.22% |
| 2015-09-30 | $0.91B | $0.53B | 58.42% |
| 2015-06-30 | $0.95B | $0.54B | 57.07% |
| 2015-03-31 | $0.86B | $0.48B | 55.97% |
| 2014-12-31 | $0.81B | $0.42B | 52.23% |
| 2014-09-30 | $0.78B | $0.40B | 50.51% |
| 2014-06-30 | $0.74B | $0.35B | 47.28% |
| 2014-03-31 | $0.76B | $0.36B | 47.56% |
| 2013-12-31 | $0.74B | $0.32B | 43.42% |
| 2013-09-30 | $0.71B | $0.29B | 41.33% |
| 2013-06-30 | $0.67B | $0.26B | 39.40% |
| 2013-03-31 | $0.67B | $0.27B | 39.64% |
| 2012-12-31 | $0.65B | $0.26B | 40.55% |
| 2012-09-30 | $0.61B | $0.24B | 38.66% |
| 2012-06-30 | $0.59B | $0.23B | 39.15% |
| 2012-03-31 | $0.54B | $0.20B | 37.57% |
| 2011-12-31 | $0.51B | $0.18B | 36.17% |
| 2011-09-30 | $0.46B | $0.13B | 27.17% |
| 2011-06-30 | $0.43B | $0.09B | 20.00% |
| 2011-03-31 | $0.41B | $0.07B | 16.55% |
| 2010-12-31 | $0.39B | $0.05B | 13.27% |
| 2010-09-30 | $0.38B | $0.06B | 15.73% |
| 2010-06-30 | $0.37B | $0.05B | 13.66% |
| 2010-03-31 | $0.37B | $0.04B | 11.78% |
